Is vitamin C an effective antihypertensive supplement? A review and analysis of the literature

Journal of Chiropractic Medicine

Volumn 5, Issue 2, 2006, Pages 60-64

  McRae, Marc P ^a  

^a NATIONAL UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Ascorbic Acid; Blood Pressure; Hypertension; Vitamin C

Indexed keywords

EID: 34848874213     PISSN: 08993467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3467(07)60134-7     Document Type: Article

References (43)

1. Burt V., Whelton P., Roccella E., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313
2. Yoshioka M., Matsushita T., and Chuman Y. Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30-39 years. Int J Vitam Nutr Res 54 (1984) 343-347
3. Bulpitt C. Vitamin C and blood pressure. J Hypertens 8 (1990) 1071-1075
4. Jacques P. Relationship of vitamin C status to cholesterol and blood pressure. Ann NY Acad Sci 669 (1992) 205-213
5. Jacques P. A cross-sectional study of vitamin C intake and blood pressure in the elderly. Int J Vitam Nutr Res 62 (1992) 252-255
6. Moran J., Cohen L., Greene J., et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 57 (1993) 213-217
7. Ness A., Khaw K., Bingham S., and Day N. Vitamin C status and blood pressure. J Hypertens 14 (1996) 503-508
8. Koh E. Effect of vitamin C on blood parameters of hypertensive subjects. J Okla State Med Assoc 77 (1984) 177-182
9. Osilesi O., Trout D., Ogunwole J., and Glover E. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nut Res 11 (1991) 405-412
10. Lovat L., Lu Y., Palmer A., Edwards R., Fletcher A., and Bulpitt C. Doubleblind trial of vitamin C in elderly hypertensives. J Hum Hypertens 7 (1993) 403-405
11. Ghosh S., Ekpo E., Shah I., Girling A., Jenkins C., and Sinclair A. A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 40 (1994) 268-272
12. Eriksson J., and Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 39 (1995) 217-223
13. Gokce N., Keaney Jr. J., Frei B., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99 (1999) 3234-3240
14. Fotherby M., Williams J., Forster L., Craner P., and Ferns G. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 18 (2000) 411-415
15. Rolla G., Brussino L., Carra R., Garbella E., and Bucca C. Hypertension and ascorbic acid. Lancet 355 (2000) 1271-1272
16. Duffy S., Gokce N., Holbrook M., et al. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 280 (2001) H528-H534
17. Darko D., Dornhorst A., Kelly F., Ritter J., and Chowienczyk P. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci (Lond) 103 (2002) 339-344
18. Hajjar I., George V., Sasse E., and Kochar M. A randomized, doubleblind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 9 (2002) 289-293
19. Mullan B., Young I., Fee H., and McCance D. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40 (2002) 804-809
20. Magen E., Viskoper R., Mishal J., et al. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 6 (2004) 742-746
21. Ness A., Chee D., and Elliott P. Vitamin C and blood pressure-an overview. J Hum Hypertens 11 (1997) 343-350
22. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
23. Whelton P., He J., Cutler J., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277 (1997) 1624-1632
24. Allender P., Cutler J., Follmann D., Cappuccio F., Pryer J., and Elliott P. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 124 (1996) 825-831
25. Russo C., Olivieri O., Girelli D., et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16 (1998) 1267-1271
26. Kedziora-Kornatowska K., Czuczejko J., Pawluk H., et al. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 9 (2004) 635-641
27. Levine G., Frei B., Koulouris S., Gerhard M., Keaney Jr. J., and Vita J. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93 (1996) 1107-1113
28. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
29. Jackson T., Xu A., Vita J., and Keaney Jr. J. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83 (1998) 916-922
30. Sherman D., Keaney Jr. J., Biegelsen E., Duffy S., Coffman J., and Vita J. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35 (2000) 936-941
31. Frei B., England L., and Ames B. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci 86 (1989) 6377-6381
32. Retsky K., Freeman M., and Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J Biol Chem 268 (1993) 1304-1309
33. Huang A., Vita J., Venema R., and Keaney Jr. J. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275 (2000) 17399-17406
34. Baker T., Milstien S., and Katusic Z. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37 (2001) 333-338
35. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., and Werner E. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276 (2001) 40-47
36. Valagussa F., Franzosi M., Geraci E., et al. Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
37. Palumbo G., Avanzini F., Alli C., et al. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)-Hypertension study. Am J Hypertens 13 (2000) 564-567
38. Yusuf S., Dagenais G., Pogue J., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 154-160
39. Galley H., Thornton J., Howdle P., Walker B., and Webster N. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond) 92 (1997) 361-365
40. Griffiths L., Brocklehurst J., Scott D., Marks J., and Blackley J. Thiamine and ascorbic acid levels in the elderly. Gerontol Clin 9 (1967) 1-10
41. Scott J., and King G. Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci 1031 (2004) 204-213
42. Sinclair A., Taylor P., Lunec J., Girling A., and Barnett A. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med 11 (1994) 893-898
43. Rivers J. Safety of high-level vitamin C ingestion. Int J Vitam Nutr Res Suppl 30 (1989) 95-102